Cyclin Dependent Kinase (CDK) Inhibitors

By Trumpp A.  

Trends in Cell Biology, Vol. 9, Iss. 3, 1999-03 ,pp. : 122-122

Elsevier

Access to resources Recommend Favorite

Synthesis and evaluation of indenopyrazoles as cyclin-dependent kinase inhibitors. Part 4: Heterocycles at C3

By Yue E.W.   DiMeo S.V.   Higley C.A.   Markwalder J.A.   Burton C.R.   Benfield P.A.   Grafstrom R.H.   Cox S.   Muckelbauer J.K.   Smallwood A.M.   Chen H.   Chang C.-H.   Trainor G.L.   Seitz S.P.  

Bioorganic and Medicinal Chemistry Letters, Vol. 14, Iss. 2, 2004-01 ,pp. : 343-346

Elsevier

Access to resources Recommend Favorite

The extracellular matrix and mitogenic growth factors control G1 phase cyclins and cyclin-dependent kinase inhibitors

By Bottazzi M.E.   Assoian R.K.  

Trends in Cell Biology, Vol. 7, Iss. 9, 1997-09 ,pp. : 348-352

Elsevier

Access to resources Recommend Favorite

Characterization of Novel Inhibitors of Cyclin-Dependent Kinases

By Kent L.L.   Hull-Campbell N.E.   Lau T.   Wu J.C.   Thompson S.A.   Nori M.  

Biochemical and Biophysical Research Communications, Vol. 260, Iss. 3, 1999-07 ,pp. : 768-774

Elsevier

Access to resources Recommend Favorite

Molecular model of cyclin-dependent kinase 5 complexed with roscovitine

By de Azevedo W.F.   Tadeu Gaspar R.   Canduri F.   Carlos Camera J.   Jose´ Freitas da Silveira N.  

Biochemical and Biophysical Research Communications, Vol. 297, Iss. 5, 2002-10 ,pp. : 1154-1158

Elsevier

Access to resources Recommend Favorite